Stuart A Arbuckle Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stuart A Arbuckle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stuart A Arbuckle. Stuart A Arbuckle is a Director in IMMUNOGEN INC ($IMGN) and a EVP, Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP\Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a Director in Cerulean Pharma Inc. ($CERU) and a Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE, 02139 MA
Companies in which Stuart A Arbuckle is an Insider
Dare Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: Director
Holdings: 13,104 shares
Current Value: $15,201
Latest Transaction: Jan 05 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: Director
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: EVP, Chief Commercial Officer, EVP\Chief Commercial Officer
Holdings: 44,737 shares
Current Value: $3,884,961
Latest Transaction: Feb 26 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stuart A Arbuckle
Sentiment: All, DARE, IMGN, RYTM, VRTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 216.57 | 254 | 55,009 | 41,103 | 41.4 K to 41.1 K (-0.61 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 215.62 | 300 | 64,686 | 41,357 | 41.7 K to 41.4 K (-0.72 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 214.32 | 400 | 85,728 | 41,657 | 42.1 K to 41.7 K (-0.95 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 213.55 | 1,400 | 298,970 | 42,057 | 43.5 K to 42.1 K (-3.22 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 212.52 | 900 | 191,268 | 43,457 | 44.4 K to 43.5 K (-2.03 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 211.39 | 380 | 80,328 | 44,357 | 44.7 K to 44.4 K (-0.85 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Payment of Exercise | F | 217.57 | 2,898 | 630,518 | 44,737 | 47.6 K to 44.7 K (-6.08 %) |